Skip to main content
profile image
Selected Works of Robert Sanchez, MD, FACC
Article
Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands
Clinical Therapeutics (2017)
  • Josephina G. Kuiper, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
  • Robert J. Sanchez, Regeneron, Tarrytown, New York
  • Eline Houben, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
  • Edith M. Heintjes, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
  • Fernie J.A. Penning-van Beest, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
  • Irfan Khan, Sanofi, Bridgewater, New Jersey
  • Melanie van Riemsdijk, Sanofi, Gouda, the Netherlands
  • Ron M.C. Herings, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
Link
Disciplines
Publication Date
April 1, 2017
DOI
10.1016/J.CLINTHERA.2017.03.001
Citation Information
Josephina G. Kuiper, Robert J. Sanchez, Eline Houben, Edith M. Heintjes, et al.. "Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands" Clinical Therapeutics Vol. 39 Iss. 4 (2017) p. 819 - 827
Available at: http://works.bepress.com/robert-sanchez/20/